Vimirogant

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameVimirogant
Drug Alias NameVTP-43742AGN-242428
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVitae
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVitae Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A